Armistice Capital LLC recently announced the acquisition of new stake in Onconetix Inc (NASDAQ:ONCO). This fresh investment now brings its stake to 6.05% valued currently at $0.27 million. In addition, Cetera Advisor Networks LLC raised its holdings by 49100.0 to 0.32 million shares. And The Vanguard Group, Inc. has lifted its position by 10.27% or 18204.0 shares – to 0.2 million shares.
With over 4.77 million Onconetix Inc (ONCO) shares trading Tuesday and a closing price of $0.21 on the day, the dollar volume was approximately $1.0 million. The shares have shown a negative half year performance of -82.64% and its price on 12/26/23 gained nearly 10.53%. Currently, there are 15.27M common shares owned by the public and among those 13.90M shares have been available to trade.
Insiders at the company have transacted a total of 8 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 7 of these insider trades were purchases, accounting for 425,440 shares. Insider sales of the common stock occurred on 1 occasions, with total insider shares sold totaling 1,200,000 shares.
The top 3 mutual fund holders in Onconetix Inc are Vanguard Total Stock Market ETF, Vanguard Extended Market Index Fu, and Fidelity Extended Market Index Fu. Vanguard Total Stock Market ETF owns 0.13 million shares of the company’s stock, all valued at over $30618.0. Fidelity Extended Market Index Fu now owns shares totaling to 0.23% of the shares outstanding.
Shares of Onconetix Inc (NASDAQ: ONCO) opened at $0.20, up $0.01 from a prior closing price of $0.19. However, the script later moved the day high at 0.2400, up 10.53%. The company’s stock has a 5-day price change of -12.28% and -63.66% over the past three months. ONCO shares are trading -80.91% year to date (YTD), with the 12-month market performance down to -80.37% lower. It has a 12-month low price of $0.16 and touched a high of $1.95 over the same period. ONCO has an average intraday trading volume of 322.64K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -12.10%, -32.74%, and -73.14% respectively.
Institutional ownership of Onconetix Inc (NASDAQ: ONCO) shares accounts for 20.01% of the company’s 15.27M shares outstanding. Mutual fund holders own 17.79%, while other institutional holders and individual stakeholders account for 20.70% and 1.33% respectively.
It has a market capitalization of $3.74M and a beta (3y monthly) value of 3.48. The earnings-per-share (ttm) stands at -$1.13. Price movements for the stock have been influenced by the stock’s volatility, which stands at 23.15% over the week and 19.93% over the month.
Analysts forecast that Onconetix Inc (ONCO) will achieve an EPS of -$0.21 for the current quarter, $0 for the next quarter and -$0.85 for 2024. The lowest estimate earnings-per-share for the quarter is -$0.21 while analysts give the company a high EPS estimate of -$0.21. Comparatively, EPS for the current quarter was -$0.2 a year ago.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 1 brokerage firm advisors rate Onconetix Inc (ONCO) as a “Strong Buy” at a consensus score of 1.00. Specifically, 0 Wall Street analysts polled rate the stock as a buy, while 1 of the 1 advise that investors “hold,” and 0 rated it as a “Sell.”
